QR 057
Alternative Names: QR-057Latest Information Update: 31 Oct 2023
Price :
$50 *
At a glance
- Originator Wuhan Createrna Science and Technology
- Class Analgesics; Antitussives; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Cough; Pain
Most Recent Events
- 23 Oct 2023 Preclinical trials in Pain in China (unspecified route) (Wuhan Createrna Science and Technology pipeline, October 2023)
- 17 Dec 2021 Preclinical trials in Cough in China (unspecified route), before December 2021 (Wuhan Createrna Science and Technology pipeline, December 2021)
- 17 Dec 2021 Wuhan Createrna Science and Technology plans to file an IND application for Cough (Wuhan Createrna Science and Technology pipeline, December 2021)